Related Experiment Videos
Helicobacter pylori eradication therapy: a discrepancy between current guidelines and clinical practice
J M Lee1, E Deasy, C A O'Morain
1Department of Gastroenterology, Meath/Adelaide Hospitals, Trinity College, Dublin, Ireland.
European Journal of Gastroenterology & Hepatology
|April 28, 2000
Summary
Helicobacter pylori eradication therapy is infrequently prescribed for ulcer healing, with most regimens initiated by primary care practitioners. Many of these regimens have unproven efficacy, contrasting with specialist practices.
Area of Science:
- Gastroenterology
- Pharmacology
- Clinical Practice
Background:
- Consensus guidelines advocate for Helicobacter pylori (H. pylori) eradication regimens in treating peptic ulcer disease and dyspepsia.
- Physician adherence to these guidelines in clinical practice remains to be firmly established.
Purpose of the Study:
- To determine the proportion of ulcer-healing prescriptions that included H. pylori eradication regimens.
- To analyze the composition of prescribed H. pylori eradication regimens.
- To compare H. pylori eradication prescribing patterns between specialists and primary care practitioners.
Main Methods:
- Prospective evaluation of prescriptions for acid-suppressing agents and H. pylori eradication regimens across seven community pharmacies.
- Data collection occurred over an initial one-month period, followed by a three-month focused evaluation of eradication regimens.
Main Results:
- H. pylori eradication therapy was prescribed for only 2.9% of 585 evaluated patients.
- Primary care practitioners initiated 73% of the 66 evaluated eradication regimens, compared to 27% by specialists.
- 72.5% of regimens were triple therapy, but 13 different combinations were identified, many with undocumented efficacy.
Conclusions:
- H. pylori eradication therapy constitutes a small fraction of current ulcer-healing prescriptions.
- Primary care practitioners predominantly initiate eradication regimens, often with unproven efficacy.
- Prescribing practices for H. pylori eradication may not fully align with consensus guidelines, particularly regarding regimen efficacy.